🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study has two phases, a dose escalation phase and a dose expansion pha...
Status
Terminated
Location
City of Hope National Medical Center
Start Date
2011-11
Trial ID
NCT01402440
Treatments Being Tested
This study is designed to provide efficacy and safety data of several doses...
Status
Completed
Location
Burke Pharmaceutical Research
Start Date
2009-04
Trial ID
NCT00885196
This study will assess safety and efficacy of AEB071 combined with everolim...
Status
Completed
Location
Argentina
Start Date
2007-07
Trial ID
NCT00504543
This study will assess the safety and efficacy of different doses of sotras...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-04
Trial ID
NCT01128335
This phase II trial studies how well sotrastaurin acetate works in treating...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-03-12
Trial ID
NCT02285244
Treatments Being Tested
Primary objective is to define the maximum tolerated dose (MTD) for the com...
Status
Completed
Location
Bascom Palmer Eye Institute of University Of Miami Medical Center
Start Date
2014-11-19
Trial ID
NCT02273219
Neoadjuvant RBP-01 in patients with primary uveal melanoma....
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-10-01
Trial ID
NCT07747935
Treatments Being Tested
This is a study to assess the safety effects after multiple doses of AEB071...
Status
Completed
Location
Novartis Investigative Site
Start Date
2006-10
Trial ID
NCT00416546
Treatments Being Tested
The purpose of this study is to assess the safety, tolerability, and effica...
Status
Completed
Location
University of Southern California Doheny Eye Institute
Start Date
2008-07
Trial ID
NCT00615693
Treatments Being Tested
This study will evaluate the efficacy, safety and tolerability of AEB071 in...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-04
Trial ID
NCT00572585